Regeneron Pharmaceuticals, Inc. (REGN) Management Presents at Barclays 26th Annual Global Healthcare Conference (Transcript)
REGNRegeneron(REGN) Seeking Alpha·2024-03-13 01:35

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Barclays 26th Annual Global Healthcare Conference Transcript March 12, 2024 11:15 AM ET Executives Chris Fenimore - Chief Financial Officer Ryan Crowe - Vice President, Investor Relations Analysts Carter Gould - Barclays Carter Gould Great. All right. Good morning. And welcome to the Barclays Global Healthcare Conference. My name is Carter Gould covering large-cap biopharma here at Barclays. Welcome, everyone. I’m pleased to welcome Regeneron Pharmaceuticals to ...